𝔖 Bobbio Scriptorium
✦   LIBER   ✦

M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-β1

✍ Scribed by Samuel Godár; Václav Hořejší; Ulrich H. Weidle; Bernd R. Binder; Cornelia Hansmann; Hannes Stockinger

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
184 KB
Volume
29
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transforming growth factor β-1 and amphi
Transforming growth factor β-1 and amphiregulin act in synergy to increase the production of urokinase-type plasminogen activator in transformed breast epithelial cells
✍ Corinne Giusti; Sylvie Desruisseau; Lin Ma; Fabien Calvo; Pierre-Marie Martin; Y 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 276 KB 👁 1 views

## Abstract Amphireguline (AR) is an epidermal growth factor (EGF)‐related peptide that seems to play an important role in breast cancer progression. We have demonstrated recently that suppression of AR expression in transformed breast epithelial cells considerably reduced both size and neovascular

Interaction and functional interplay bet
Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-β receptor complex
✍ Francisco J. Blanco; Juan F. Santibanez; Mercedes Guerrero-Esteo; Carmen Langa; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB

## Abstract Transforming growth factor‐β (TGF‐β) signaling in endothelial cells is able to modulate angiogenesis and vascular remodeling, although the underlying molecular mechanisms remain poorly understood. Endoglin and ALK‐1 are components of the TGF‐β receptor complex, predominantly expressed i

Down-regulation of protein and mRNA expr
Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer
✍ Yanping Guo; Stephen C. Jacobs; Natasha Kyprianou 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 298 KB 👁 1 views

Transforming growth factor-b (TGF-b1) is a potent negative regulator of cell growth that transduces signals through interactions with type I and II receptors. Abnormal expression and mutational alterations of these receptors have been observed in several human malignancies. In this study, we investi